Mistral Ventures and Fuse Science Poised for Growth as Push for Healthy Living Accelerates
The Bedford Report Provides Equity Research on Fuse Science & Mistral Ventures
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 11/29/11 -- Be it through through vitamins, supplements or diet books, average Americans are looking for ways to improve their health. Obesity is an extreme problem in North America and with a growing push for healthy living, a number of nutrition stocks could see some upside. The Bedford Report examines the outlook for companies in the Nutrition industry and provides investment research on Fuse Science Inc. (PINKSHEETS: DROP) and Mistral Ventures, Inc. (PINKSHEETS: MILV). Access to the full company reports can be found at:
Additionally, high performance athletes continue to seek efficient ways to absorb nutrients when the body is at its highest demand. Athletic supplements have gone from a small niche sector to a multi-billion dollar industry. Fuse Science is the developer of new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.
Earlier this month Fuse Science announced that it has entered into an exclusive endorsement agreement with Tiger Woods in the sports nutrition and energy categories. Woods will endorse Fuse Science as a primary spokesperson in professional sports. Over the last two months, Fuse Science also has signed endorsement contracts with Tampa Bay cornerback Ronde Barber and Houston Texans running back Arian Foster.
The Bedford Report provides investors with an excellent first step in their due diligence by providing daily trading ideas, and consolidating the public information available on them. For more investment research on the Nutrition industry register with us free at and get exclusive access to our numerous stock reports and industry newsletters.
Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc., develops and acquires the rights to natural medicine formulas that are geared towards treating specific medical conditions. Earlier this month Nature's Bioceuticals announced that it has finalized an agreement to purchase all rights to a novel Weight loss formula. According to the company's press releases "dieters in the current economy continue to shift to less costly retail and do-it-yourself options such as: meal replacements, OTC diet pills, mail order plans, diet websites, and fad diet books. This trend is very positive for us and we are excited to enter this market by storm."
The Bedford Report provides Market Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. The Bedford Report has not been compensated by any of the above-mentioned publicly traded companies. The Bedford Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at
Contact:
The Bedford Report
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.11.2011 - 13:16 Uhr
Sprache: Deutsch
News-ID 91867
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 220 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Mistral Ventures and Fuse Science Poised for Growth as Push for Healthy Living Accelerates"
steht unter der journalistisch-redaktionellen Verantwortung von
The Bedford Report (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
